Zobrazeno 1 - 4
of 4
pro vyhledávání: '"S W, Baumgartner"'
Autor:
E H, Giannini, N T, Ilowite, D J, Lovell, C A, Wallace, C E, Rabinovich, A, Reiff, G, Higgins, B, Gottlieb, N G, Singer, Y, Chon, S-L, Lin, S W, Baumgartner, Laura, Schanberg
Publikováno v:
Arthritis and rheumatism. 60(9)
Objective This study was undertaken to evaluate the long-term safety and effectiveness of etanercept alone or in combination with methotrexate (MTX) in children with selected categories of juvenile idiopathic arthritis (JIA). Methods Patients ages 2
Autor:
L W, Moreland, S B, Cohen, S W, Baumgartner, E A, Tindall, K, Bulpitt, R, Martin, M, Weinblatt, J, Taborn, A, Weaver, D J, Burge, M H, Schiff
Publikováno v:
The Journal of rheumatology. 28(6)
Patients with rheumatoid arthritis (RA) treated with etanercept (Enbrel) in controlled studies of 3 to 6 months' duration had rapid and sustained improvement of their disease, with minimal safety issues. In this study, we examine safety and clinical
Autor:
S W, Baumgartner
Publikováno v:
Southern medical journal. 93(8)
Biologic agents that target molecules and cells involved in chronic inflammation are coming into clinical use for the treatment of rheumatoid arthritis (RA). New agents block the action of cytokines, which play a key role in the pathogenesis of RA. A
Publikováno v:
Clinical therapeutics. 9
An open-label comparison of diflunisal, a nonacetylated salicylate nonsteroidal anti-inflammatory drug (NSAID), and piroxicam, an NSAID belonging to the oxicam family, was conducted in patients with osteoarthritis. Efficacy assessments were made biwe